Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs Late Conversion to Advagraf in Liver Transplant
NCT02105155Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2014
- Primary completion
- Oct 2016
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in Liver transplant rejection, sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2014; status: completed.
02
Drugs
tacrolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT02105155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02105155.